Connect with us

Health

 Data remains essential document for risk assessments of COVID-19 – WHO

Published

on

The World Health Organisation (WHO) says data remains essential for the organisation to carry out regular, rapid and robust risk assessments of the current situation of COVID-19.

Dr Tedros Ghebreyesus, WHO Director-General, said this during an online media briefing on COVID-19.

Ghebreyesus called on China to share the data on COVID-19 and also conduct studies on how to prevent future pandemics.

“With circulation in China so high and comprehensive data not forthcoming, it is understandable that some countries are taking steps they believe will protect their own citizens.

“This data is useful to WHO and the world and we encourage all countries to share it.

“We continue to ask China for more rapid, regular, reliable data on hospitalisations and deaths, as well as more comprehensive, real-time viral sequencing,’’ he said.

WHO boss said that the organisation was concerned about the risk to life in China and has reiterated the importance of vaccination, including booster doses, to protect against hospitalisation, severe disease, and death.

According to him, this is especially important for older people, those with underlying medical conditions, and others who are at higher risk of severe outcomes.

Ghebreyesus said that the dawn of a New Year in many countries offered a collective moment for both reflection and ambition for the year ahead.

“Now into the fourth year of the pandemic, the world is in a much better place than it was several years ago, due to clinical care management, vaccines and treatments.

“For most of last year, COVID-19 was on the decline.

“Vaccination increased across the world, and there was sustained progress in many low- and middle-income countries that had been left far behind in 2021.

“Such is due to vaccine nationalism and manufacturing capacity being restricted to just a handful of countries,’’ Ghebreyesus said.

He said that new lifesaving antivirals were identified in 2022, which helped cut mortality further, although the roll out followed a similar pattern of rich countries first.

According to him, WHO is working to improve access and on Christmas Day announced that the antivirals Nirmatrelvir and Ritonavir were prequalified for production by an Indian manufacturer.

He said that it was the first generic version of an antiviral to get WHO approval and should lead to increased production and access; particularly in lower- and middle-income countries.

The WHO boss said that in spite of clear progress, the threat of COVID-19 persists.

‘`There are still major inequities in access to testing, treatment and vaccination and ultimately COVID-19 remains a dangerous virus to our health, economies and societies overall.

“Every week, approximately ten thousand people die of COVID-19, that we are aware of; the true toll is likely much higher.

“We are really concerned about the current COVID-19 epidemiological picture, with both intense transmission in several parts of the world and a recombinant sub-variant spreading quickly,’’ Ghebreyesus said.

According to him, in recent weeks, there has been increasing reports of hospitalisation and health system pressure, particularly in temperate regions of the northern hemisphere where respiratory diseases including flu are also circulating.

He said that in late December, WHO held a high-level meeting with counterparts in China to discuss the surge in cases and hospitalisations.

He said they also had meeting with WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution and the COVID-19 clinical management expert network groups both met with Chinese experts.

Health

KDSG trains 180 Red Cross volunteers on Lassa Fever intervention

Published

on

The Kaduna State Ministry of Health has begun a three-day training for 180 Red Cross volunteers on Lassa fever intervention.

The training, which is facilitated by the ministry and funded by the Red Cross, is meant to equip the volunteers selected from 5 LGAs in the state with necessary skills.

The volunteers were drawn from Zaria, Igabi, Kaduna South, Kaduna North and Chikun Divisions.

The State Epidemiologist, Dr Jeremiah Dikwu, said the volunteers were trained with  the knowledge needed to massively intervene during cases of Lassa fever in the state.

He said that the intervention would include Risk Communication and Active Case Search, Psychological First Aid, Rodent Control and Hygiene Promotion for the next 3 months.

Dikwu said the training started  with 30 volunteers on surveillance and would end with the training of 150 volunteers on Risk Communication and Community Engagement .

According to him, Lassa fever is a viral hemorrhagic fever transmitted by rats.

He added that Lassa fever  has been known since the 1950s, but the virus was not identified until 1969, when two missionary nurses died from it in the town of Lassa in Nigeria.

Dikwu added that Lassa fever was caused by a single stranded RNA virus and disseminated systemic primary viral infection.

“The main feature of fatal illness is impaired or delayed cellular immunity leading to fulminant viraemia,” he said

The epidemiologist said that Lassa fever presented  symptoms and signs indistinguishable from those of febrile illnesses such as malaria and other viral hemorrhagic fevers such as Ebola.

“It is difficult to diagnose clinically but should be suspected in patients with fever (e”38°C) not responding adequately to antimalarial and antibiotic drugs.

“The most useful clinical predictors of Lassa fever are fever, pharyngitis, retrosternal pain, and proteinuria for diagnosis; and fever, sore throat, and vomiting for outcome,” Dikwu said.

He said that Ribavirin and general support were needed.

“Ribavirin is almost twice as effective when given intravenously as when taken orally, and if given within six days of the start of illness it may reduce deaths by 90 percent.

“Dehydration, oedema, hypotension, and poor renal function are common; fluid replacement or the use of blood transfusion requires careful monitoring,” he said.

 Dikwu said the volunteers would  be carrying out Risk communication and Community engagement, Active Case Search, Psychological First Aid, Rodent Control and Hygiene Promotion

Continue Reading

Health

Assembly passes Kano Pre-Marital Health Screening Bill

Published

on

Kano State House of Assembly has passed a bill for a law to compel intending couples to undergo HIV, hepatitis and sickle cell anaemia screening before marriage.

The passage followed deliberations in the Committee of the Whole House during plenary session,
presided over by the Speaker, Ismail Falgore on Monday in Kano.

After deliberations, the lawmakers approved the 3rd reading of the bill, read by the Deputy Clerk, Alhaji Nasiru Magaji.

Shortly after passage of the bill, the Majority Leader of the house, Lawan Hussein (NNPP-Dala), stated that “any person
intending to marry shall first submit self for medical examinations.”

He said the bill was considered and passed after the 3rd reading, following various legislative processes.

The leader further said that the bill was passed because the state had been battling with different health issues, including
HIV because people go into marriages without medical screening.

He said that the bill, if signed into law, would save many lives and curb the spread of life-threatening diseases.

“The bill will safeguard the health of citizens by institutionalising pre-marital testing to check the spread of diseases
like hepatitis, HIV and sickle cell anaemia,” he added.

Continue Reading

Health

WHO to begin vaccination against Human Papilloma Virus May 27 in Kogi

Published

on

The World Health Organisation (WHO), says it plans to commence vaccination against Human Papilloma Virus (HPV) on May 27 in Kogi.

The state’s Team Lead of WHO, Dr Muktar Toyosi, said this when he led his team on an advocacy visit to the State Council of the Nigeria Union of Journalists (NUJ) on Wednesday in Lokoja.

Toyosi said that the vaccination was meant for girl child of between the age nine and 14.

He said the ongoing sensitisation was to keep the people informed, and educate them on the vaccination of their children to protect them against cervical cancer in future.

”Kogi falls within the second phase of the programme. We are soliciting for the cooperation of the media in educating the people of the state on the HPV vaccination.

“There need for girls child across the state to take the vaccination to safeguard their future.

“Although the vaccine was initially scarce and difficult to get, the good news now is that it has been made available by the government,” Toyosi said.

Also speaking, the State Technical Assistant for WHO, Dr Ahmed Attah, said that the HPV mostly affect women, adding that the vaccination remained a preventive measure against the disease.

Attah, a former state Chairman of the Nigeria Medical Association (NMA) and a former Chief Medical Director (CMD), Kogi Specialist Hospital (KSSH) Lokoja, urged parents and guardians to avail their children of the vaccination to justify government’s investment.

In his response, the Kogi NUJ Chairman, Mr Seidu Ademu, described the health sector as very critical, stressing that the vaccination was a right step in the right direction.

Ademu promised a robust partnership with WHO to enable the team to achieve its set goals.
He stressed the need to inform, educate and sensitise the general public on the need to embrace the vaccine by ensuring that girls within the age range were vaccinated.

Continue Reading

Trending